BioAge Labs, Inc. (BIOA) › Cash & EquivalentsBioAge Labs, Inc. (BIOA) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $21.64M2024: $354.35M2025: $188.89M$188.89M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$188.89M-46.7%2024$354.35M+1537.2%2023$21.64M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share